Xu CX - Search Results

1

Augmentation of NVP-BEZ235's anticancer activity against human lung cancer cells by blockage of autophagy.

Xu CX, Zhao L, Yue P, Fang G, Tao H, Owonikoko TK, Ramalingam SS, Khuri FR, Sun SY. Xu CX, et al. Cancer Biol Ther. 2011 Sep 15;12(6):549-55. doi: 10.4161/cbt.12.6.16397. Epub 2011 Sep 15. Cancer Biol Ther. 2011. PMID: 21738008 Free PMC article.

2

Apoptosis and apoptosis-based therapy in lung cancer.

Xu CX, Jin H, Cho MH. Xu CX, et al. Anticancer Agents Med Chem. 2009 Nov;9(9):952-7. doi: 10.2174/187152009789377682. Anticancer Agents Med Chem. 2009. PMID: 19663788 Review.

3

Roles of protein kinase B/Akt in lung cancer.

Xu CX, Jin H, Shin JY, Kim JE, Cho MH. Xu CX, et al. Front Biosci (Elite Ed). 2010 Jun 1;2(4):1472-84. doi: 10.2741/e206. Front Biosci (Elite Ed). 2010. PMID: 20515818 Free article. Review.

4

The combination of RAD001 and NVP-BEZ235 exerts synergistic anticancer activity against non-small cell lung cancer in vitro and in vivo.

Xu CX, Li Y, Yue P, Owonikoko TK, Ramalingam SS, Khuri FR, Sun SY. Xu CX, et al. PLoS One. 2011;6(6):e20899. doi: 10.1371/journal.pone.0020899. Epub 2011 Jun 14. PLoS One. 2011. PMID: 21695126 Free PMC article.

5

Decreased expression of miR216a contributes to non-small-cell lung cancer progression.

Wang RT, Xu M, Xu CX, Song ZG, Jin H. Wang RT, et al. Among authors: xu m, xu cx. Clin Cancer Res. 2014 Sep 1;20(17):4705-16. doi: 10.1158/1078-0432.CCR-14-0517. Epub 2014 Jun 23. Clin Cancer Res. 2014. PMID: 24958806

6

miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.

Xu M, Jin H, Xu CX, Sun B, Song ZG, Bi WZ, Wang Y. Xu M, et al. Among authors: xu cx. Mol Ther. 2015 Jan;23(1):89-98. doi: 10.1038/mt.2014.197. Epub 2014 Oct 8. Mol Ther. 2015. PMID: 25292190 Free PMC article.

7

IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non-Small Cell Lung Cancer with Activating Mutations of EGFR.

Challa S, Guo JP, Ding X, Xu CX, Li Y, Kim D, Smith MA, Cress DW, Coppola D, Haura EB, Cheng JQ. Challa S, et al. Among authors: xu cx. Cancer Res. 2016 Aug 1;76(15):4418-29. doi: 10.1158/0008-5472.CAN-16-0069. Epub 2016 Jun 10. Cancer Res. 2016. PMID: 27287717 Free PMC article.

8

Genistein promotes ionizing radiation-induced cell death by reducing cytoplasmic Bcl-xL levels in non-small cell lung cancer.

Zhang Z, Jin F, Lian X, Li M, Wang G, Lan B, He H, Liu GD, Wu Y, Sun G, Xu CX, Yang ZZ. Zhang Z, et al. Among authors: xu cx. Sci Rep. 2018 Jan 10;8(1):328. doi: 10.1038/s41598-017-18755-3. Sci Rep. 2018. PMID: 29321496 Free PMC article.

9

KRAS^Q61H Preferentially Signals through MAPK in a RAF Dimer-Dependent Manner in Non-Small Cell Lung Cancer.

Zhou ZW, Ambrogio C, Bera AK, Li Q, Li XX, Li L, Son J, Gondi S, Li J, Campbell E, Jin H, Okoro JJ, Xu CX, Janne PA, Westover KD. Zhou ZW, et al. Among authors: xu cx. Cancer Res. 2020 Sep 1;80(17):3719-3731. doi: 10.1158/0008-5472.CAN-20-0448. Epub 2020 Jun 30. Cancer Res. 2020. PMID: 32605999 Free article.

10

The miR-23a/27a/24 - 2 cluster drives immune evasion and resistance to PD-1/PD-L1 blockade in non-small cell lung cancer.

Luo H, Hu B, Gu XR, Chen J, Fan XQ, Zhang W, Wang RT, He XD, Guo W, Dai N, Jian D, Li Q, Xu CX, Jin H. Luo H, et al. Among authors: xu cx. Mol Cancer. 2024 Dec 31;23(1):285. doi: 10.1186/s12943-024-02201-w. Mol Cancer. 2024. PMID: 39736629 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters